Company Name: Pressure BioSciences, Inc.
Trading Symbol: PBIO
Address: 14 Norfolk Avenue, South Easton, MA 02375
Phone: (508) 230-1828
Market Value: $5,301,996
Authorized Shares: 100,000,000
Outstanding Shares: 21,165,654
(All information was obtained from OTCmarkets.com)
Pressure BioSciences, Inc. (“PBI”) is a publicly-traded company (OTCQB: PBIO) focused on solving the challenging problems inherent in biological sample preparation, a crucial laboratory step performed by an estimated 500,000 scientists worldwide working in biological life sciences research.
Sample preparation is a term that refers to a wide range of activities that precede virtually all forms of scientific analysis. Sample preparation is often complex, time-consuming, and one of the most error-prone steps of scientific research. It is none-the-less a ubiquitous laboratory undertaking whose requirements drive a large and growing market, worldwide.
We have developed and patented a novel, enabling technology platform that can exquisitely control the sample preparation process. It is based on harnessing the unique properties of an entirely new dimension in thermodynamics for life sciences laboratories – cycled hydrostatic pressure. This cutting-edge process, called pressure cycling technology (“PCT”), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 100,000 psi) to safely, conveniently, and reproducibly control the actions of molecules in biological samples (e.g., cells and tissues from human, animal, plant, and microbial sources).
We began operations in 2006, following the sale of our parent company Boston Biomedica, Inc.(NASDAQ: BBII). Initial sales of our instruments began in 2008, and consisted of prototype and firstgeneration units. From 2008 to present, with the information continuously received from the customers of our early generation instruments, we developed a number of PCT-based products for use by the life sciences’ market, including five pressure generating instruments (“Barocyclers”), a unique patent- pending, mechanical sample homogenization device (the “PCT Shredder”), six unique, single-use processing containers (PULSE Tubes, MicroTubes, BaroFlex 8-well processing strips, and ShredderTubes), six different reagent kits, and a number of ready-to-use, application-specific protocols. Many of these products and protocols are covered by claims in our 24 issued US and foreign patents. We have additional patent applications on file.
We believe the overall market for biological sample preparation products is very large. As stated, virtually every laboratory engaged in any form of biological research is faced with the necessity of routinely preparing samples prior to testing and analysis. The Emmes Group (2008) estimated that this market is comprised of up to 80,000 laboratories and 500,000 researchers worldwide. A report produced by BCC Research LLC, a well regarded provider of market intelligence, estimated that the global market for sample preparation reagents and products used in life science research was $4.6 billion in 2012 and is expected to reach $5.4 billion in 2013. BCC Research projects the market to grow to $11.5 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 16.3% from 2013 to 2018.
There are a number of existing methods used by scientists for biological sample preparation, including mortar and pestle grinding, sonication, homogenization, and bead beating. We believe that PCT offers significant advantages over these methods, including safety, speed, reproducibility, versatility, and ease-of-use, often with a substantial increase in the quality of the final results. There are a growing number of scientific publications and presentations from independent laboratories that we believe highlight and confirm these clear advantages of PCT over other current methods.
For much more in-depth information on this fantastic company, please visit their website using the link above. We hope you enjoyed the audio interview with PBIO’s CEO Richard Schumacher!